Erasca (ERAS) Short-term Investments (2020 - 2026)
Erasca (ERAS) posted Short-term Investments of $196.5 million for Q1 2026, down 2.84% on a QoQ basis from $202.3 million in Q4 2025, and down 16.05% year-over-year from $234.1 million in Q1 2025.
Erasca (ERAS) Short-term Investments (2020 - 2026) Analysis & Trends
Erasca's Short-term Investments history runs 7 years deep, the most recent figure standing at $196.5 million for Q1 2026.
- Quarterly Short-term Investments fell 16.05% year-over-year to $196.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $196.5 million (down 16.05% YoY) and the FY2025 annual result came in at $202.3 million, down 12.27% from the prior year.
- Short-term Investments was $196.5 million for Q1 2026 at Erasca, down from $202.3 million in the prior quarter.
- Across five years, Short-term Investments topped out at $250.0 million in Q3 2024 and bottomed at $59.2 million in Q1 2022.
- A 5-year average of $184.8 million and a median of $202.3 million in 2025 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2022 — Short-term Investments surged 234.69% — and 2026, when it retreated 16.05%.
- Erasca's Short-term Investments stood at $151.4 million in 2022, then jumped by 44.83% to $219.3 million in 2023, then grew by 5.15% to $230.6 million in 2024, then dropped by 12.27% to $202.3 million in 2025, then fell by 2.84% to $196.5 million in 2026.
- Business Quant data shows ERAS's Short-term Investments at $196.5 million in Q1 2026, $202.3 million in Q4 2025, and $218.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196.53 Mn |
| Dec 31, 2025 | 202.27 Mn |
| Sep 30, 2025 | 218.17 Mn |
| Jun 30, 2025 | 234.52 Mn |
| Mar 31, 2025 | 234.10 Mn |
| Dec 31, 2024 | 230.57 Mn |
| Sep 30, 2024 | 250.03 Mn |
| Jun 30, 2024 | 235.61 Mn |
| Mar 31, 2024 | 220.96 Mn |
| Dec 31, 2023 | 219.28 Mn |
| Sep 30, 2023 | 183.81 Mn |
| Jun 30, 2023 | 178.46 Mn |
| Mar 31, 2023 | 116.99 Mn |
| Dec 31, 2022 | 151.40 Mn |
| Sep 30, 2022 | 136.67 Mn |
| Jun 30, 2022 | 73.47 Mn |
| Mar 31, 2022 | 59.19 Mn |
| Dec 31, 2021 | 53.99 Mn |
| Sep 30, 2021 | 40.83 Mn |
| Jun 30, 2021 | 37.28 Mn |